- Home
- LADR vs IRMD Comparison
LADR vs IRMD Comparison
Compare LADR & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LADR | IRMD |
|---|---|---|
| Founded | 2008 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2013 | 2014 |
Fundamental Metrics
Financial Performance| Metric | LADR | IRMD |
|---|---|---|
| Price | $9.34 | $85.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | $11.79 | ★ $118.00 |
| AVG Volume (30 Days) | ★ 1.8M | 76.9K |
| Earning Date | 10-16-2026 | 11-06-2026 |
| Dividend Yield | ★ 9.87% | 0.91% |
| EPS Growth | N/A | ★ 16.67 |
| EPS | 0.14 | ★ 0.86 |
| Revenue | N/A | ★ $83,814,000.00 |
| Revenue This Year | $13.86 | $9.85 |
| Revenue Next Year | $2.27 | $13.07 |
| P/E Ratio | ★ $66.68 | $101.40 |
| Revenue Growth | N/A | ★ 14.43 |
| 52 Week Low | $8.48 | $75.75 |
| 52 Week High | $11.48 | $107.90 |
Technical Indicators
Market Signals| Indicator | LADR | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 57.51 | 43.79 |
| Support Level | $8.48 | $85.00 |
| Resistance Level | $10.45 | $88.59 |
| Average True Range (ATR) | 0.22 | 2.15 |
| MACD | 0.10 | -0.12 |
| Stochastic Oscillator | 95.06 | 25.66 |
Price Performance
Historical ComparisonAbout LADR Ladder Capital Corp
Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments: Loans, which derive maximum revenue; Securities; and Real Estate.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.